Skip to main content

OBAGI C RX system C CLARIFYING SERUM

NDC 62032-106 · Obagi Cosmeceuticals LLC

Generic nameHYDROQUINONE
Dosage formSOLUTION
RouteTOPICAL
Active ingredient(s)HYDROQUINONE
Strength40 mg/mL
Pharmacologic classDepigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]
Marketing categoryUNAPPROVED DRUG OTHER

Packages

62032-106-10 — 1 BOTTLE, GLASS in 1 CARTON (62032-106-10) / 30 mL in 1 BOTTLE, GLASS

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0299-5950 — fluocinolone acetonide, hydroquinone, and tretinoin, 10135-724 — hydroquinone, 24689-101 — Hydroquinone, 30815-0040 — Hydroquinone, 42192-151 — Hydroquinone, 42851-035 — Hydroquinone, 42851-036 — Hydroquinone, 42851-037 — Hydroquinone, 50405-800 — Hydroquinone, 62032-100 — HYDROQUINONE, 62032-101 — HYDROQUINONE, 62032-105 — HYDROQUINONE, 62032-116 — HYDROQUINONE, OCTINOXATE, and OXYBENZONE, 62032-122 — HYDROQUINONE, 69367-174 — Hydroquinone, 71399-0400 — Hydroquinone, 71421-801 — Hydroquinone, 72162-2422 — Hydroquinone, 75834-137 — Hydroquinone

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels